Tuberculosis in the tropics
- 1 September 1993
- journal article
- tropical health
- Published by AMPCo in The Medical Journal of Australia
- Vol. 159 (6) , 412-415
- https://doi.org/10.5694/j.1326-5377.1993.tb137920.x
Abstract
Until recently tuberculosis was considered a well controlled disease, at least in developed countries. In developing countries, more than seven million people are affected by active tuberculosis. This situation is exacerbated by poor infrastructure to support tuberculosis control measures and the interaction between tuberculosis and infection with the human immunodeficiency virus. The three major strategies for controlling tuberculosis remain BCG vaccination in children, appropriate preventive therapy and, most importantly, reducing the sources of infection through case finding and curative treatment. Research and resources to improve on these strategies should be given high priority by the international health community. (Med J Aust 1993; 159: 412‐415)Keywords
This publication has 14 references indexed in Scilit:
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infectionTubercle and Lung Disease, 1992
- An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1992
- The Impact of Human Immunodeficiency Virus Infection on Tuberculosis and Its ControlChest, 1991
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosisThe Lancet, 1991
- Bacillus Calmette—Guérin immunization in infants born to HIV-1-seropositive mothersAIDS, 1991
- Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Mycobacterial diseasesThe Lancet, 1990
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989